search
Back to results

EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA

Primary Purpose

Rosacea

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Perfecta V-Beam laser
Sponsored by
Syneron Medical
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rosacea

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Subjects must have a Fitzpatrick skin type of I-IV and have Rosacea as evaluated by the treating physician.
  • Subjects must have visible telangiectasia on the side of the face.
  • Subjects must be willing and able to comply with all follow-up requirements.
  • Subjects must be willing and able to apply sunblock SPF of 30 while exposed to the sun.
  • Subject willing to have photographs taken and used in presentations or publications.

Exclusion Criteria:

  • Subjects must not have had a previous laser treatment, deep chemical peel in the intended treatment site(s) within 6 months prior to treatment, oral retinoids within 6 months of their inclusion into this study or have ever taken gold therapy.
  • Subjects must not have a history of keloid formation.
  • Subjects with Fitzpatrick Classification of V or VI (to reduce the risk of hyper-pigmentation).
  • Subjects must be willing and able to comply with all follow-up requirements.
  • Subjects cannot have vitiligo, a condition where pigment is lost in the skin and white patches appear).
  • Subjects not willing to avoid sun exposure or not will to apply sunblock SPF of 30 while exposed to the sun.
  • Subject not willing to have photographs taken and used in presentations, publications and marketing material

Sites / Locations

    Outcomes

    Primary Outcome Measures

    The percentage reduction in the facial redness and telangiectasias of rosacea
    The percentage reduction in the facial redness and telangiectasias of rosacea will be determined by the investigators using polarized photography for each subject

    Secondary Outcome Measures

    Full Information

    First Posted
    July 5, 2017
    Last Updated
    July 9, 2017
    Sponsor
    Syneron Medical
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03211585
    Brief Title
    EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA
    Official Title
    EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA (FACIAL REDNESS, TELANGIECTASIAS AND PHOTODAMAGE)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2016 (Actual)
    Primary Completion Date
    April 2018 (Anticipated)
    Study Completion Date
    December 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Syneron Medical

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to further quantify the safety and effectiveness of the Syneron-Candela long pulse-duration, extended sub-pulse, larger spot-size prototype Perfecta V-Beam, 595nm laser system for the treatment of facial redness associated with flushing and blushing, or rosacea. The Perfecta laser system is expected to provide effective treatment of rosacea with less bruising or purpura and greater effectiveness than previous generation systems. This study should enable optimization of treatment parameters for using the Perfecta 595nm laser for treating rosacea.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Rosacea

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    20 (Actual)

    8. Arms, Groups, and Interventions

    Intervention Type
    Device
    Intervention Name(s)
    Perfecta V-Beam laser
    Intervention Description
    This s a single study and a prototype of the FDA-cleared, flashlamp-pumped pulsed-dye laser, that is currently on the market, that has evolved over almost 25 years of continuous development. The broad-spectrum flashlamp pumps energy into a cavity containing liquid dye. The dye is excited resulting in the emission of 595 nm orange light.
    Primary Outcome Measure Information:
    Title
    The percentage reduction in the facial redness and telangiectasias of rosacea
    Description
    The percentage reduction in the facial redness and telangiectasias of rosacea will be determined by the investigators using polarized photography for each subject
    Time Frame
    two months following the final treatment

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Subjects must have a Fitzpatrick skin type of I-IV and have Rosacea as evaluated by the treating physician. Subjects must have visible telangiectasia on the side of the face. Subjects must be willing and able to comply with all follow-up requirements. Subjects must be willing and able to apply sunblock SPF of 30 while exposed to the sun. Subject willing to have photographs taken and used in presentations or publications. Exclusion Criteria: Subjects must not have had a previous laser treatment, deep chemical peel in the intended treatment site(s) within 6 months prior to treatment, oral retinoids within 6 months of their inclusion into this study or have ever taken gold therapy. Subjects must not have a history of keloid formation. Subjects with Fitzpatrick Classification of V or VI (to reduce the risk of hyper-pigmentation). Subjects must be willing and able to comply with all follow-up requirements. Subjects cannot have vitiligo, a condition where pigment is lost in the skin and white patches appear). Subjects not willing to avoid sun exposure or not will to apply sunblock SPF of 30 while exposed to the sun. Subject not willing to have photographs taken and used in presentations, publications and marketing material
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Eric Bernstein, MD
    Organizational Affiliation
    Main Line Center for Laser Surgery
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA

    We'll reach out to this number within 24 hrs